EP3487494 - LACTAMS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 29.05.2020 Database last updated on 14.11.2024 | |
Former | Request for examination was made Status updated on 26.04.2019 | ||
Former | The international publication has been made Status updated on 26.01.2018 | ||
Former | unknown Status updated on 25.07.2017 | Most recent event Tooltip | 26.07.2024 | New entry: Renewal fee paid | Applicant(s) | For:AL
AT
BE
BG
CH
CZ
DK
EE
ES
FI
FR
GR
HR
HU
IS
LI
LT
LU
LV
MC
MK
NL
NO
PL
PT
RO
RS
SE
SI
SK
SM
TR
Unilever IP Holdings B.V. Weena 455 3013 AL Rotterdam / NL | For:CY
DE
GB
IE
IT
MT
Unilever Global IP Limited Port Sunlight Wirral, Merseyside CH62 4ZD / GB | [2022/08] |
Former [2021/39] | For:AL
AT
BE
BG
CH
CZ
DK
EE
ES
FI
FR
GR
HR
HU
IS
LI
LT
LU
LV
MC
MK
NL
NO
PL
PT
RO
RS
SE
SI
SK
SM
TR
Unilever IP Holdings B.V. Weena 455 3013 AL Rotterdam / NL | ||
For:CY
DE
GB
IE
IT
MT
Unilever Global IP Limited Port Sunlight Wirral, CH62 AZD / GB | |||
Former [2019/22] | For:CY
GB
IE
MT
Unilever PLC Unilever House 100 Victoria Embankment London, Greater London EC4Y 0DY / GB | ||
For:AL
AT
BE
BG
CH
CZ
DE
DK
EE
ES
FI
FR
GR
HR
HU
IS
IT
LI
LT
LU
LV
MC
MK
NL
NO
PL
PT
RO
RS
SE
SI
SK
SM
TR
Unilever N.V. Weena 455 3013 AL Rotterdam / NL | Inventor(s) | 01 /
PARRY, Neil, James Unilever R&D Port Sunlight Quarry Road East Bebington, Wirral Merseyside CH63 3JW / GB | 02 /
PANTALONE, Paolo University of Nottingham Centre for Biomolecular Sciences School of Life Sciences Nottingham, Nottinghamshire NG7 2RD / GB | 03 /
WILLIAMS, Paul University of Nottingham Centre for Biomolecular Sciences School of Life Sciences Nottingham, Nottinghamshire NG7 2RD / GB | [2019/22] | Representative(s) | McHugh, Paul Edward Unilever Patent Group Bronland 14 6708 WH Wageningen / NL | [N/P] |
Former [2019/22] | McHugh, Paul Edward Unilever PLC Unilever Patent Group Colworth House Sharnbrook, Bedford Bedfordshire MK44 1LQ / GB | Application number, filing date | 17739289.1 | 13.07.2017 | [2019/22] | WO2017EP67782 | Priority number, date | EP20160180612 | 21.07.2016 Original published format: EP 16180612 | [2019/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018015279 | Date: | 25.01.2018 | Language: | EN | [2018/04] | Type: | A1 Application with search report | No.: | EP3487494 | Date: | 29.05.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.01.2018 takes the place of the publication of the European patent application. | [2019/22] | Search report(s) | International search report - published on: | EP | 25.01.2018 | Classification | IPC: | A61K31/4015, A61P31/00, A61K31/402, A61K31/40 | [2019/22] | CPC: |
A61K31/402 (EP,US);
C07D207/44 (US);
A61K31/40 (EP);
A61K31/4015 (EP,US);
A61K9/0073 (US);
A61P11/00 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/22] | Title | German: | LACTAME ZUR BEHANDLUNG VON ATEMWEGSINFEKTIONEN | [2019/22] | English: | LACTAMS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS | [2019/22] | French: | LACTAMES SERVANT AU TRAITEMENT DES INFECTIONS DES VOIES RESPIRATOIRES | [2019/22] | Entry into regional phase | 13.02.2019 | National basic fee paid | 13.02.2019 | Designation fee(s) paid | 13.02.2019 | Examination fee paid | Examination procedure | 13.02.2019 | Examination requested [2019/22] | 13.02.2019 | Date on which the examining division has become responsible | 09.09.2019 | Amendment by applicant (claims and/or description) | 03.06.2020 | Despatch of a communication from the examining division (Time limit: M06) | 14.12.2020 | Reply to a communication from the examining division | 06.12.2022 | Despatch of a communication from the examining division (Time limit: M06) | 01.06.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 25.07.2019 | Renewal fee patent year 03 | 23.07.2020 | Renewal fee patent year 04 | 26.07.2021 | Renewal fee patent year 05 | 27.07.2022 | Renewal fee patent year 06 | 26.07.2023 | Renewal fee patent year 07 | 25.07.2024 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2007085042 (BIOSIGNAL LTD [AU], et al) [X] 1-7,9,10 * page 33 - page 34; table 2 * * page 8, line 5 - line 11 * * page 22 * * compound 219; page 40 * * claims 7,8 * * page 7, line 23 - page 8, line 2 * * page 8, line 16 - page 9, line 4 * [I] 8; | [A]WO2014118240 (UNILEVER PLC [GB], et al) [A] 1-10 * page 7 * * claims *; | [A]WO2014183164 (KUMAR NARESH [AU], et al) [A] 1-10 * claim 7 * * page 25 - page 26 ** page 5 * | by applicant | WO2007085042 | WO2014118240 | WO2014183164 | - AENDEKERK S; DIGGLE SP; SONG Z; HOIBY N; CORNELIS P; WILLIAMS P; CAMARA M., "The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication", Microbiology, (20050000), vol. 151, no. 4, pages 1113 - 25 | - BARR HL; HALLIDAY N; CAMARA M; BARRETT DA; WILLIAMS P; FORRESTER DL; SIMMS R; SMYTH AR; HONEYBOURNE D; WHITEHOUSE JL, "Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis.", European Respiratory Journal, (20150000), vol. 46, no. 4, pages 1046 - 1054 | - FLETCHER MP; DIGGLE SP; CAMARA M; WILLIAMS, P., "Biosensor-based assays for PQS, HHQ and related 2-alkyl-4-quinolone quorum sensing signal molecules", Nature Protocols, (20070000), vol. 2, pages 1254 - 1262 | - FLETCHER MP; DIGGLE SP; CAMARA M.; WILLIAMS P., "Biosensor-based assays for PQS, HHQ and related 2-alkyl-4-quinolone quorum sensing signal molecules", Nature protocols, (20070000), vol. 2, pages 1254 - 62 | - FRESCHI et al., "Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium", Frontiers in microbiology, (20150000), vol. 6 | - ILANGOVAN A; FLETCHER M; RAMIONI G; PUSTELNY C; RUMBAUGH K; HEEB S; CAMARA M; TRUMAN A; CHHABRA SR; EMSLEY J, "Structural basis for native agonist and synthetic inhibitor recognition by the Pseudomonas aeruginosa quorum sensing regulator PqsR (MvfR).", PLOS Pathogens, (20130000), vol. 9, no. 7, page e1003508 | - NIEWERTH H; BERGANDER K; CHHABRA S; WILLIAMS P; FETZNER S., "Synthesis and biotransformation of 2-alkyl-4(1 H)-quinolones by recombinant Pseudomonas putida KT2440", Applied Microbiology and Biotechnology, (20110000), vol. 91, pages 1399 - 1408 | - RAHME LG; STEVENS EJ; WOLFORT SF; SHAO J; TOMPKINS RG et al., "Common virulence factors for bacterial pathogenicity in plants and animals", Science, (19950000), vol. 268, pages 1899 - 1902 |